Cargando…

Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine: a multisite, randomised, double-blind, placebo-controlled trial

BACKGROUND: A monovalent, parenteral, subunit rotavirus vaccine was well tolerated and immunogenic in adults in the USA and in toddlers and infants in South Africa, but elicited poor responses against heterotypic rotavirus strains. We aimed to evaluate safety and immunogenicity of a trivalent vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Groome, Michelle J, Fairlie, Lee, Morrison, Julie, Fix, Alan, Koen, Anthonet, Masenya, Maysseb, Jose, Lisa, Madhi, Shabir A, Page, Nicola, McNeal, Monica, Dally, Len, Cho, Iksung, Power, Maureen, Flores, Jorge, Cryz, Stanley
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science ;, The Lancet Pub. Group 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322558/ https://www.ncbi.nlm.nih.gov/pubmed/32251641 http://dx.doi.org/10.1016/S1473-3099(20)30001-3

Ejemplares similares

Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial
por: Groome, Michelle J, et al.
Publicado: (2017)

Association between Immunogenicity of a Monovalent Parenteral P2-VP8 Subunit Rotavirus Vaccine and Fecal Shedding of Rotavirus following Rotarix Challenge during a Randomized, Double-Blind, Placebo-Controlled Trial
por: Fellows, Tamika, et al.
Publicado: (2023)

Neutrophil Counts in Healthy South African Infants: Implications for Enrollment and Adverse Event Grading in Clinical Trials in an African Setting
por: Koen, Anthonet, et al.
Publicado: (2019)

Formulation and preclinical studies with a trivalent rotavirus P2-VP8 subunit vaccine
por: Lakatos, Kyle, et al.
Publicado: (2020)

A Nanoparticle-Based Trivalent Vaccine Targeting the Glycan Binding VP8* Domains of Rotaviruses
por: Xia, Ming, et al.
Publicado: (2021)

FUT2 Secretor Status Influences Susceptibility to VP4 Strain-Specific Rotavirus Infections in South African Children
por: MacDonald, Jaime, et al.
Publicado: (2020)

Recombinant Subunit Rotavirus Trivalent Vaccine Candidate: Physicochemical Comparisons and Stability Evaluations of Three Protein Antigens
por: Agarwal, Sanjeev, et al.
Publicado: (2019)

Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccine
por: Lappalainen, Suvi, et al.
Publicado: (2015)

Characterizing and Minimizing Aggregation and Particle Formation of Three Recombinant Fusion-Protein Bulk Antigens for Use in a Candidate Trivalent Rotavirus Vaccine
por: Agarwal, Sanjeev, et al.
Publicado: (2020)

Effect of HIV-exposure and timing of anti-retroviral treatment on immunogenicity of trivalent live-attenuated polio vaccine in infants
por: Moonsamy, Shelina, et al.
Publicado: (2019)

Parenteral protein-based rotavirus vaccine
por: O’Ryan, Miguel, et al.
Publicado: (2017)

Human rotavirus VP4 and VP7 genetic diversity and detection of GII norovirus in Ibadan as Nigeria introduces rotavirus vaccine
por: Maina, Meshach Maunta, et al.
Publicado: (2022)

The rotavirus VP5*/VP8* conformational transition permeabilizes membranes to Ca(2+)
por: De Sautu, Marilina, et al.
Publicado: (2023)

The SRL peptide of rhesus rotavirus VP4 protein governs cholangiocyte infection and the murine model of biliary atresia
por: Mohanty, Sujit K., et al.
Publicado: (2017)

Parenterally Administered P24-VP8* Nanoparticle Vaccine Conferred Strong Protection against Rotavirus Diarrhea and Virus Shedding in Gnotobiotic Pigs
por: Ramesh, Ashwin, et al.
Publicado: (2019)

Antibody Kinetics and Response to Routine Vaccinations in Infants Born to Women Who Received an Investigational Trivalent Group B Streptococcus Polysaccharide CRM(197)-Conjugate Vaccine During Pregnancy
por: Madhi, Shabir A, et al.
Publicado: (2017)

An in-vitro transcription assay for development of Rotavirus VP7
por: Jalilian, Shahram, et al.
Publicado: (2017)

Classification of group A rotavirus VP7 and VP4 genotypes using random forest
por: Tran, Hoc, et al.
Publicado: (2023)

Quantification of trivalent non-replicating rotavirus vaccine antigens in the presence of aluminum adjuvant
por: McAdams, David, et al.
Publicado: (2021)

Immunogenicity of Seven-Valent Pneumococcal Conjugate Vaccine Administered at 6, 14 and 40 Weeks of Age in South African Infants
por: Jones, Stephanie A., et al.
Publicado: (2013)

Bivalent rotavirus VP4∗ stimulates protective antibodies against common genotypes of human rotaviruses
por: Luo, Guoxing, et al.
Publicado: (2022)

Intracellular neutralisation of rotavirus by VP6-specific IgG
por: Caddy, Sarah L., et al.
Publicado: (2020)

Association of serum anti-rotavirus immunoglobulin A antibody seropositivity and protection against severe rotavirus gastroenteritis: Analysis of clinical trials of human rotavirus vaccine
por: Cheuvart, Brigitte, et al.
Publicado: (2014)

Trivalent Combination Vaccine Induces Broad Heterologous Immune Responses to Norovirus and Rotavirus in Mice
por: Tamminen, Kirsi, et al.
Publicado: (2013)

Evaluation of Intussusception After Oral Monovalent Rotavirus Vaccination in South Africa
por: Groome, Michelle J, et al.
Publicado: (2020)

Strain-Specific Interactions between the Viral Capsid Proteins VP4, VP7 and VP6 Influence Rescue of Rotavirus Reassortants by Reverse Genetics
por: Valusenko-Mehrkens, Roman, et al.
Publicado: (2023)

The Functional Characterization of Bat and Human P[3] Rotavirus VP8*s
por: Li, Dandi, et al.
Publicado: (2021)

Molecular determinants of rotavirus virulence: Localization of a potential virulence site in a murine rotavirus VP4
por: Ijaz, M.K., et al.
Publicado: (1994)

HLA antibody repertoire in infants suggests selectivity in transplacental crossing
por: Savulescu, Dana M., et al.
Publicado: (2020)

Rotavirus A strains obtained from children with acute gastroenteritis in Mozambique, 2012-2013: G and P genotypes and phylogenetic analysis of VP7 and partial VP4 genes
por: João, Eva Dora, et al.
Publicado: (2017)

Trivalent influenza vaccination randomized control trial of pregnant women and adverse fetal outcomes
por: Simões, Eric A.F., et al.
Publicado: (2019)

Vaccinomics Approach for Multi-Epitope Vaccine Design against Group A Rotavirus Using VP4 and VP7 Proteins
por: Usman, Muhammad, et al.
Publicado: (2023)

Identifying gaps in hand hygiene practice to support tailored target audience messaging in Soweto: A cross-sectional community survey
por: Johnstone, Siobhan L., et al.
Publicado: (2022)

Processing of rotavirus glycoprotein VP7: implications for the retention of the protein in the endoplasmic reticulum
Publicado: (1987)

Primary sequence domains required for the retention of rotavirus VP7 in the endoplasmic reticulum
Publicado: (1988)

Antigenicity and Immunogenicity of Rotavirus VP6 Protein Expressed on the Surface of Lactococcus lactis
por: Esteban, L. E., et al.
Publicado: (2013)

Anti-VP6 VHH: An Experimental Treatment for Rotavirus A-Associated Disease
por: Maffey, Lucía, et al.
Publicado: (2016)

Silencing the alarms: Innate immune antagonism by rotavirus NSP1 and VP3
por: Morelli, Marco, et al.
Publicado: (2015)

Glycan binding patterns of human rotavirus P[10] VP8* protein
por: Pang, Li-li, et al.
Publicado: (2018)

Rotavirus VP6 as an Adjuvant for Bivalent Norovirus Vaccine Produced in Nicotiana benthamiana
por: Malm, Maria, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sqb56gq4pqj4038pj7u10ok7dc